A new study published in Ecology Letters has uncovered the mechanisms underlying plant community assembly and biodiversity ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

LAHORE: Artificial intelligence (AI) is enabling researchers to uncover new cancer applications for widely used medicines by ...

New research published in the peer-reviewed science journal, Immuno, reports that Hericium erinaceus (Lion's Mane) off-the-shelf mushroom mycelium-based products may have distinct advantages when ...

BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with Ottimo Pharma Limited ("Ottimo"), an innovative, ...

AI Foundation Model for Tumor and Immune Biology to Guide Precision Patient Selection for Novel Bifunctional OTP-01 BostonGene, the developer of the leading AI foundation model for tumor and immune ...

Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...

The maternal microbiome and immune system have both independent and synergistic effects on fetal brain health—changes in the ...

BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, science-led biopharmaceutical company ...

Biology has always been an unruly science. Cells divide when they want to. Genes switch on and off like temperamental lights.

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

The maternal microbiome and immune system have both independent and synergistic effects on fetal brain health - changes in ...